Keywords: morphosys, expands, boeh, ing, accord, synthetic, antibody

MorphoSys expands Boeh Ing R&D accord

Article | 20 November 2006

Synthetic antibody specialist MorphoSys AG says that its partner, fellow Germany-based Boehringer Ingelheim, has exercised an option for optimizing a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing